PHS
MDCO

PFM Health Sciences’s Medicines Co MDCO Stock Holding History

PFM Health Sciences’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,561,640
Closed -$76.6M – 134
2018
Q3 		$76.6M Buy
2,561,640
+472,643
+23% +$17.8M 1.12% 34
2018
Q2 		$76.7M Sell
2,088,997
-114,334
-5% -$3.72M 1.2% 25
2018
Q1 		$72.6M Buy
2,203,331
+358,279
+19% +$11.2M 1.47% 25
2017
Q4 		$50.4M Buy
1,845,052
+344,049
+23% +$10.6M 1.2% 36
2017
Q3 		$55.6M Sell
1,501,003
-311,999
-17% -$11.5M 1.09% 34
2017
Q2 		$68.9M Sell
1,813,002
-37,633
-2% -$1.68M 1.86% 19
2017
Q1 		$90.5M Sell
1,850,635
-866,806
-32% -$39.5M 2.27% 10
2016
Q4 		$92.2M Buy
2,717,441
+969,243
+55% +$34.4M 2.6% 6
2016
Q3 		$66M Sell
1,748,198
-870,556
-33% -$32.8M 1.93% 16
2016
Q2 		$88.1M Buy
2,618,754
+392,547
+18% +$13.8M 2.66% 8
2016
Q1 		$70.7M Buy
2,226,207
+159,660
+8% +$5.21M 2.18% 19
2015
Q4 		$77.2M Buy
2,066,547
+776,895
+60% +$29.4M 2.34% 13
2015
Q3 		$49M Sell
1,289,652
-12,864
-1% -$452K 1.38% 25
2015
Q2 		$37.3M Buy
+1,302,516
New +$36.3M 0.94% 41
2015
Q1 		– Sell
-946,830
Closed -$26.2M – 106
2014
Q4 		$26.2M Buy
946,830
+57,716
+6% +$1.43M 0.61% 51
2014
Q3 		$19.8M Buy
889,114
+412,180
+86% +$10.5M 0.46% 46
2014
Q2 		$13.9M Buy
+476,934
New +$12.7M 0.28% 57
2014
Q1 		– Sell
-2,116,102
Closed -$81.7M – 91
2013
Q4 		$81.7M Sell
2,116,102
-248,999
-11% -$8.9M 1.64% 21
2013
Q3 		$79.3M Buy
+2,365,101
New +$75.3M 1.91% 20

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PFM Health Sciences's MDCO Position: Q4 2018 in Review

PFM Health Sciences sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 2,561,640 shares — an estimated $76.6M sold.

PFM Health Sciences first reported a position in MDCO in Q3 2013 and held it in 19 quarters. The position peaked at $92.2M in Q4 2016. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • PFM Health Sciences reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 2,561,640 Medicines Co shares in Q4 2018, an estimated $76.6M.
  • PFM Health Sciences first reported a position in Medicines Co in Q3 2013 and held it in 19 quarters.
  • PFM Health Sciences's Medicines Co position peaked at $92.2M in Q4 2016.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.